{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:33:17Z","timestamp":1772253197774,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.diagmicrobio.2007.02.010","type":"journal-article","created":{"date-parts":[[2007,4,21]],"date-time":"2007-04-21T07:10:29Z","timestamp":1177139429000},"page":"363-365","source":"Crossref","is-referenced-by-count":48,"title":["In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection"],"prefix":"10.1016","volume":"58","author":[{"given":"Mark S.","family":"Rouse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Steckelberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib1","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1128\/AAC.49.10.4210-4219.2005","article-title":"Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin","volume":"49","author":"Bogdanovich","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib2","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","first-page":"M07-A7","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib3","series-title":"Performance standards for antimicrobial susceptibility testing; 16th informational supplement","first-page":"M100-S-16","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib5","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/AAC.00272-06","article-title":"In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals","volume":"50","author":"Denis","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2004.04.011","article-title":"Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates","volume":"50","author":"Deshpande","year":"2004","journal-title":"Diagn. Microbiol. Infect Dis."},{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/AAC.45.3.825-836.2001","article-title":"In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci","volume":"45","author":"Hebeisen","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/jac\/dkf249","article-title":"In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci","volume":"50","author":"Jones","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JCM.44.2.595-597.2006","article-title":"Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis","volume":"44","author":"Marty","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jac\/42.2.189","article-title":"Glycopeptide tolerance in Staphylococcus aureus","volume":"42","author":"May","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib11","series-title":"Methods for determining bactericidal activity of antimicrobial agents; approved guideline","first-page":"M26-A","author":"National Committee for Clinical Laboratory Standards","year":"1999"},{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib12","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/cncr.21801","article-title":"Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer","volume":"106","author":"Safdar","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.diagmicrobio.2007.02.010_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/AAC.00576-06","article-title":"High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm","volume":"51","author":"Weigel","year":"2007","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889307000983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889307000983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T21:52:27Z","timestamp":1546897947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889307000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0732889307000983"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2007.02.010","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}